ZA9810358B - 19-Nor steroids substituted in position 11beta, preparation process and intermediates, their use as medicaments and pharmaceutical compositions containing them. - Google Patents

19-Nor steroids substituted in position 11beta, preparation process and intermediates, their use as medicaments and pharmaceutical compositions containing them.

Info

Publication number
ZA9810358B
ZA9810358B ZA9810358A ZA9810358A ZA9810358B ZA 9810358 B ZA9810358 B ZA 9810358B ZA 9810358 A ZA9810358 A ZA 9810358A ZA 9810358 A ZA9810358 A ZA 9810358A ZA 9810358 B ZA9810358 B ZA 9810358B
Authority
ZA
South Africa
Prior art keywords
medicaments
intermediates
pharmaceutical compositions
preparation process
compositions containing
Prior art date
Application number
ZA9810358A
Other languages
English (en)
Inventor
Francois Nique
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ZA9810358B publication Critical patent/ZA9810358B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9810358A 1997-11-17 1998-11-12 19-Nor steroids substituted in position 11beta, preparation process and intermediates, their use as medicaments and pharmaceutical compositions containing them. ZA9810358B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714357A FR2771096B1 (fr) 1997-11-17 1997-11-17 Nouveaux 19-nor steroides, substitues en position 11beta, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
ZA9810358B true ZA9810358B (en) 1999-11-12

Family

ID=9513422

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810358A ZA9810358B (en) 1997-11-17 1998-11-12 19-Nor steroids substituted in position 11beta, preparation process and intermediates, their use as medicaments and pharmaceutical compositions containing them.

Country Status (25)

Country Link
US (2) US6479476B1 (tr)
EP (1) EP1032584B1 (tr)
JP (1) JP4476480B2 (tr)
KR (1) KR20010032127A (tr)
CN (1) CN1286694A (tr)
AR (1) AR016012A1 (tr)
AT (1) ATE232542T1 (tr)
AU (1) AU754846B2 (tr)
BR (1) BR9814201A (tr)
CA (1) CA2309242A1 (tr)
CZ (1) CZ20001799A3 (tr)
DE (1) DE69811393T2 (tr)
EA (1) EA003133B1 (tr)
ES (1) ES2192341T3 (tr)
FR (1) FR2771096B1 (tr)
HR (1) HRP20000315A2 (tr)
HU (1) HUP0100210A3 (tr)
ID (1) ID24236A (tr)
IL (1) IL136148A0 (tr)
NO (1) NO20002483L (tr)
PL (1) PL340381A1 (tr)
SK (1) SK7052000A3 (tr)
TR (1) TR200001405T2 (tr)
WO (1) WO1999025725A1 (tr)
ZA (1) ZA9810358B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2780060B1 (fr) 1998-06-23 2000-08-04 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
DE19929715A1 (de) * 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
FR2826004B1 (fr) * 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
FR2854403B1 (fr) 2003-04-29 2008-07-11 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes
CA3006267C (en) * 2014-11-26 2023-08-29 The Regents Of The University Of California Estrogen receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978657A (en) * 1981-01-09 1990-12-18 Roussel Uclaf Novel 11β-substituted-19-nor-steroids
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
ID24236A (id) 2000-07-13
AU1242699A (en) 1999-06-07
DE69811393D1 (de) 2003-03-20
US20030073675A1 (en) 2003-04-17
SK7052000A3 (en) 2000-12-11
HUP0100210A3 (en) 2001-12-28
JP2001523687A (ja) 2001-11-27
PL340381A1 (en) 2001-01-29
TR200001405T2 (tr) 2001-05-21
HUP0100210A1 (hu) 2001-08-28
CZ20001799A3 (cs) 2001-11-14
NO20002483L (no) 2000-07-17
EP1032584B1 (fr) 2003-02-12
WO1999025725A1 (fr) 1999-05-27
CN1286694A (zh) 2001-03-07
EP1032584A1 (fr) 2000-09-06
ATE232542T1 (de) 2003-02-15
AU754846B2 (en) 2002-11-28
ES2192341T3 (es) 2003-10-01
IL136148A0 (en) 2001-05-20
DE69811393T2 (de) 2003-08-28
EA200000530A1 (ru) 2000-10-30
FR2771096B1 (fr) 2000-08-11
HRP20000315A2 (en) 2000-10-31
KR20010032127A (ko) 2001-04-16
BR9814201A (pt) 2000-09-26
EA003133B1 (ru) 2003-02-27
AR016012A1 (es) 2001-05-30
JP4476480B2 (ja) 2010-06-09
NO20002483D0 (no) 2000-05-12
US6479476B1 (en) 2002-11-12
CA2309242A1 (fr) 1999-05-27
FR2771096A1 (fr) 1999-05-21
US6693090B2 (en) 2004-02-17

Similar Documents

Publication Publication Date Title
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
IL128601A0 (en) 7alpha-(epsilon-aminoalkyl) estratrienes, process for preparing the same, pharmaceutical preparation containing said 7alpha-(epsilon-aminoalkyl) estratrienes and their use for preparing medicaments
HUP0100136A3 (en) 11-or 17-substituted estratriols, process for their preparation, use of them and pharmaceutical compositions containing the same
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
HUP9801045A3 (en) Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation
HUP9801044A3 (en) Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0102307A3 (en) Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0000426A3 (en) Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HU9800781D0 (en) Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use
AU1166895A (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-onederivatives, process for their preparation and the pharmaceutical compositions containing them
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
HUP0003577A3 (en) Tetrahydro gamma-carbolines, process for their preparation, their use and pharmaceutical compositions containing them
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HUT77375A (hu) Enterokinetikus hatású benzamidszármazékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
ZA9810358B (en) 19-Nor steroids substituted in position 11beta, preparation process and intermediates, their use as medicaments and pharmaceutical compositions containing them.
ZA973289B (en) Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them.
ZA989781B (en) Novel bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them.
ZA983046B (en) 4-Halogenated steroids their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them